Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
0.769
+0.037 (5.03%)
At close: Nov 22, 2024, 4:00 PM
0.799
+0.030 (3.96%)
After-hours: Nov 22, 2024, 7:21 PM EST
Seres Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$5.63
Upside
+632.50%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,201.07% | Nov 14, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $1.25 | Strong Buy | Maintains | $1.25 | +62.63% | Nov 13, 2024 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Oct 24, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,201.07% | Sep 13, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +1,201.07% | Aug 14, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $1.25 | Strong Buy | Maintains | $1.25 | +62.63% | Aug 14, 2024 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jun 7, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | +1,201.07% | Jun 7, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +420.43% | May 9, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $8 → $6 | Strong Buy | Maintains | $8 → $6 | +680.64% | May 8, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $9 → $5 | Buy | Maintains | $9 → $5 | +550.53% | Mar 6, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +940.85% | Mar 6, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 → $9 | Buy | Maintains | $10 → $9 | +1,070.96% | Jan 16, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $4 → $1.25 | Strong Sell | Maintains | $4 → $1.25 | +62.63% | Nov 3, 2023 |
| Oppenheimer | Oppenheimer | Buy Initiates $12 | Buy | Initiates | $12 | +1,461.28% | Jun 26, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +1,201.07% | Apr 28, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.